ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

SLNO Soleno Therapeutics Inc

45,12
-4,11 (-8,35%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Soleno Therapeutics Inc SLNO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-4,11 -8,35% 45,12 00:14:04
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
47,14 44,98 48,49 45,12 49,23
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.5.202404:32GLOBESoleno Therapeutics Announces Pricing of Approximately $138..
02.5.202422:01GLOBESoleno Therapeutics Announces Proposed Public Offering of..
30.4.202414:00GLOBESoleno Therapeutics Announces Peer-Reviewed Publication of..
29.4.202414:00GLOBESoleno Therapeutics Receives Breakthrough Therapy..
19.4.202422:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
08.3.202422:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
07.3.202412:06EDGAR2Form 8-K - Current report
06.3.202422:05GLOBESoleno Therapeutics Provides Corporate Update and Reports..
22.2.202414:00GLOBESoleno Therapeutics to Present at the TD Cowen 44th Annual..
31.1.202422:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
30.1.202422:57EDGAR2Form 8-K - Current report
29.1.202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202422:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
24.1.202414:00GLOBESoleno Therapeutics Strengthens Leadership Team with Key..
17.1.202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
08.1.202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:16EDGAR2Form 8-K - Current report
05.1.202414:00GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
02.1.202422:06EDGAR2Form S-3ASR - Automatic shelf registration statement of..
16.12.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202301:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202323:09EDGAR2Form 144 - Report of proposed sale of securities
14.12.202303:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202303:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202322:53EDGAR2Form 144 - Report of proposed sale of securities
13.12.202322:46EDGAR2Form 144 - Report of proposed sale of securities
13.12.202300:17EDGAR2Form 144 - Report of proposed sale of securities
12.12.202301:05EDGAR2Form 144 - Report of proposed sale of securities
05.12.202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202302:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202303:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202303:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202303:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.11.202322:05GLOBESoleno Therapeutics Announces Inducement Grants Under Nasdaq..
07.11.202314:00GLOBESoleno Therapeutics Provides Corporate Update and Reports..
06.11.202314:00GLOBESoleno Therapeutics Announces Peer-Reviewed Publication of..
01.11.202305:15EDGAR2Form EFFECT - Notice of Effectiveness
20.10.202322:32EDGAR2Form S-3 - Registration statement under Securities Act of..
16.10.202322:30EDGAR2Form SC 13D/A - General statement of acquisition of..
12.10.202322:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11.10.202322:30EDGAR2Form SC 13D/A - General statement of acquisition of..
10.10.202322:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05.10.202300:16GLOBECorrecting & Replacing -- Soleno Therapeutics Announces DCCR..
04.10.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:05GLOBESoleno Therapeutics Announces DCCR Data Presentation at the..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock